Musculoskeletal (MSK) diseases affect a substantial proportion of the population. Specialist consultations were offered at the workplace for people with musculoskeletal (MSK)-complaints. We analyzed data on pain and well-being as well as health economic data at baseline. Lasting effects of the consultation were analyzed at a follow-up-interview after 12 months. Baseline data of 344 individuals were available. Occupations were divided into physically highly demanding (HD) or less demanding. Women reported significantly higher pain levels and less QoL than men. Sick leave days were significantly more in HD-workers. Independent of workload, significantly higher percentages of women had cervical-and upper limb-pain than men, with significantly higher pain in upper limbs in HD-workers. 235 participants were available for telephone-follow-up. QoL and MSK-pain improved significantly. Yearly out-of-pocket spendings for treatments significantly increased. NSAID use significantly decreased, whereas use of non-drug musculoskeletal-medical-services was significantly higher after one year. Regarding MSK-symptoms in gainfully employed individuals, the study showed significantly different workload-dependent differences in QoL. Significant effects of a consultation by a MSKspecialist were shown in terms of improved MSK-pain and overall well-being. This workplace-centered consultation had significant effects on beneficial health-behavior such as decreased use of NSAID and increased engagement in gymnastics and physiotherapy.
Methods
Four Austrian companies were approached via the companies' medical services and employee representatives. The companies were selected with the aim to reach a broad variety of occupations/professions of the employees: a large hospital, a large bank, a pharmaceutical company, and a company manufacturing heavy equipment for use in mining, transportation, and the energy industry. Due to this variety it was anticipated to reach employees with mainly sedentary work as well as workers with high physical demand. In two companies (hospital, heavy equipment manufacturer), employees' work could be grouped into "highly physically demanding/HD" (e.g. housekeeping, welders, nurses, cooks etc.) and "less physically demanding/LD" (administrators, clerical personnel, physicians, accountants etc.) according to Austrian federal law 16 . The employees of the other two companies (a bank and a pharmaceutical company) were solely engaged in "less physically demanding" occupations.
All companies participate in an Austrian program aimed at improving health at the workplace ("betriebliche Gesundheitsförderung"), which encourages companies to offer health benefits to their employees in various ways.
The employees were asked to participate in the project via e-mail and/or paper leaflets. In this step they received a questionnaire (the Nordic questionnaire) 17 in order to detect early signs or symptoms of MSDs. All individuals in whom the Nordic questionnaire indicated presence of a MSK problem were offered an anonymous screening consultation, i.e. the employer had no information about the identity of the participants. Because the questionnaire in this context was merely used as an alert/incentive (at least one question answered with "yes") for the employees to accept the offer of a consultation, and because of the requirement to preserve anonymity no further analysis of e.g. prevalence of MSK symptoms or body-regions involved was performed. Appointments for the consultation were scheduled by the employees via the companies' medical services which are required to keep any personal information confidential, i.e. hidden from the employer.
The consultation took place close to the workplace, e.g. in the offices of the companies' medical service or physician(s) and was performed by specialists for internal medicine and rheumatology or orthopedic specialists. These specialists performed a primary check for presence of MSDs. This included a brief history, a symptom centered physical examination and, if applicable, a brief history of previous od current treatments. All individuals received a brief medical recommendation and, if possible/necessary, were given a referral to a practice/ outpatient clinic specialized in MSDs (Orthopedic, Rheumatologic, Rehabilitation/Physical Medicine) in order to facilitate timely specialist treatment. The cooperating practices ensured rapid admissions upon referral under this program.
The study was supported by an unrestricted grant from by AbbVie. AbbVie furthermore covered the costs of the specialists' consultations.
Participants and study procedures. All individuals undergoing consultation by the MSD-specialists were asked to participate in the follow-up study. If the probands agreed to be followed up, the following data were obtained using a structured questionnaire: (i) demographic information (such as age, gender, employment status), (ii) known diagnoses/comorbidities (MSD and others), (iii) duration of complaints, (iv) intensity of MSK pain (measured on a 100 mm visual analogue scale (VAS)) 18 , (v) intensity of pain related to non-MSD conditions, (vi) affected region(s), (vii) medical or non-medical treatment used so far: non-steroidal antirheumatic drugs (NSAIDs), low-(non-opioid), intermediate-(weak opioids such as tramadol), and high-potency-(strong opioids such as morphine etc.) analgesics according to WHO 19 , glucocorticoids, other medication, physiotherapy, others, www.nature.com/scientificreports www.nature.com/scientificreports/ (viii) number of doctor visits during the preceding year, (ix) out of pocket costs for medical treatments during the preceding year, and (x) number of days of sick leave due to MSK complaints and due to other conditions/ diseases during the preceding year. If the duration of symptoms exceeded 10 years, '120 months' was recorded. The specialists' suspected diagnosis/diagnoses and recommendations for further management were recorded at the screening visit. For analysis of diagnoses, all patients' suspected diagnoses were grouped into the following categories: RA (Rheumatoid arthritis), spondyloarthritis (SpA; this group encompasses ankylosing spondylitis, psoriatic arthritis, and arthritis associated with inflammatory bowel disease), connective tissue diseases (CTD), fibromyalgia syndrome/central sensitivity syndrome (FMS/CSS), osteoarthritis (OA), 'other inflammatory' MSD (such as reactive arthritis, viral arthritis, gout, etc.) and 'other non-inflammatory' MSD (such as herniated disc, hypermobility syndrome, spondylolisthesis, scoliosis, etc.).
In addition, participants received the following questionnaires: Euroquol-5d (EQ-5d), a general well-being questionnaire 20 , Hospital Anxiety And Depression Scale (HADS-D), a depression inventory 21 , and Functional Assessment of Chronic Illness Therapy (FACIT) Fatigue scale 22 . For follow-up after one year, participants were contacted by telephone. The following information was collected via a structured interview by two of the authors (HL and MH) blinded to the baseline data of the participants: (i) diagnosis, (ii) therapy during the intervening months between baseline and follow-up, (iii) general wellbeing assessed by numerical rating scale (NRS), (iv) intensity of pain assessed by NRS, (v) number of doctor consultations during the intervening months since baseline visit for both MSDs and non-MSD conditions, (vi) costs for treatments (out of pocket payments not covered by health insurance), and (vii) sick leave days since inclusion in the study due to MSDs as well as sick leave days since inclusion in the study due to non-MSDs.
The study was approved by the ethics committee of the Medical University of Vienna and conducted according to the Declaration of Helsinki. Written informed consent was obtained from all participants in the follow-up study.
Statistical analysis.
All recorded data were entered into an electronic storage. Analyses were performed using SPSS Version 24 (IBM Analytics, Ehningen, Germany Tables) . Because of the exploratory nature of the study, no sample size calculation was performed.
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Results
Participants. The numbers of employees invited to participate in the program was 3500 in the bank, 125 in the pharmaceutical company, 2070 in the hospital, and 475 in the heavy equipment manufacturer. The proportion of "HD" employees was 26% (n = 539) in the hospital, and 37.1% (n = 176) in the heavy equipment manufacturer.
Between October 2014 and December 2016, 413 individuals (approximately 6.7% of all those who had been notified and offered the consultation), participated in the program; 344 individuals (83,3%) consented to being enrolled in the present study. 102 individuals were lost to follow-up and 7 were excluded due to interim development of medical conditions. Therefore 235 individuals were evaluable for follow-up analysis (Fig. 1 ). Demographic and baseline data are shown in Table 1 .
Only 71 of 344 individuals (20.9%) reported to have had to take sick leave days in the year before the consultation. Eight individuals had more than one month of sick leave because of MSDs in the year before the baseline consultation.
Before the MSD-specialist consultation no participant had been diagnosed with RA or CTD. 2 (0.6%) reported a known diagnosis of SpA, 1 (0.3%) FMS/CSS, 33 (9.6%) OA, 4 (1.2%) 'other inflammatory' diseases (such as reactive arthritis, viral arthritis, gout, etc.) and 109 (31.7%) 'other non-inflammatory' disease (such as frozen shoulder, herniated vertebral disk, cervical syndrome, spondylosis etc.). 195 (56.6%) participants reported no previous diagnosis of MSD. For further analysis of baseline data, participants were grouped according to gender and HD and LD occupations resulting in 8 "subgroups" which were compared to each other (Table 2 ). Women reported less quality of life (EQ-5d scale) compared with men, HD working women had the least quality of life and LD working men indicated the highest values on the EQ-5d scale. This group also reported to have the least MSK pain on the VAS scale compared to the other groups. In line with other epidemiologic studies, women reported significantly higher levels of pain than men. The number of sick leave days as well as the number of individuals who reported having taken at least one sick leave day during the preceding year due to MSD conditions were quite low overall, with a statistically significantly higher number in HD workers. Likewise, HD workers had consulted a physician for MSD-complaints during the preceding year significantly more frequently than LD workers, and women reported about twice as many physician visits because of MSDs compared with men.
On the FACIT fatigue scale women had a significantly worse score compared to men with no other significant differences in the various intergroup-comparisons. Both the HADS-D anxiety-as well as HADS-D depression score did not show significant differences in the intergroup analysis.
Regarding the HADS-D depression score and the FACIT score HD working participants also showed worse scores overall which, however, did not reach level of significance. Likewise, no significant intergroup differences were apparent regarding duration of complaints, pain rating due to other reasons than MSDs, number of medical consultations because of other reasons than MSDs, sick leave days due to other diseases than MSDs and out of pocket payments (Table 2) .
With regard to painful body regions and independent of the workload, women showed significantly higher percentages of cervical-and upper limb-pain issues than men. There were significant differences between LD and HD regarding pain in upper limbs. Lower back pain was distributed equally among the groups. HD-working women additionally complained significantly more frequently about lower limb pain (Table 3) .
Follow-up. For follow-up by telephone interview 235 participants (68%) were available. When asked to verbally rate their general wellbeing on a 0-100 scale (analogous to the EQ-5d scale), participants reported a significant improvement. Likewise, the rating of pain due to MSDs improved. In parallel, yearly out of pocket payments significantly increased at follow-up (Fig. 2) . This was observed in all participants, regardless whether or not they were suspected by the specialist during the workplace assessment to suffer from MSDs. Days of sick leave and the number of medical consultations for MSD or non-MSD conditions per participant did not differ significantly during follow-up from the period before the consultation. During the year before the consultation at baseline, 44 of the 235 individuals for whom follow-up data were available had at least one sick-leave day due to MSD-complaints (18.7%), during the ensuing year, this number dropped to 34 (14.5%; p = 0.2150). www.nature.com/scientificreports www.nature.com/scientificreports/ The proportion of participants using NSAIDs decreased significantly from 28.1% to 17.4%, whereas we found significantly higher rates of use of conservative MSK medical services (physiotherapy, gymnastics/sports, physical therapy and complementary/alternative methods), 22.1% vs. 70.2% using any type of these methods (Table 4) .
Median IQR Range
Intergroup analysis confirmed the results as described above and did not show further significant differences between gender or physical workload groups.
Because for follow-up only 235 participants' data (68.3%) were available, we performed a sensitivity analysis in which all missing data were set as "unchanged", with no effect on the outcomes (i.e. all the differences remained significant).
Discussion
In this study, we assessed the effects of short MSD-intervention/consultation on several outcomes related to health, sickness absence and use of health care and other services. The employees were offered an intervention which consisted of a brief consultation by a specialist for MSDs (Rheumatologist or Orthopedic surgeon) very Table 2 . Intergroup analysis at baseline. Data from the subgroups are shown in the left side of the table.
If analysis by Kruskal-Wallis ANOVA indicated significant intergroup differences (10 th column from left), pairwise intergroup comparisons were done (right side of the table). For clarity, p-values are omitted in case of non-significance in the initial test. Due to significant differences of variances between groups, post-hoc group comparisons were done by Games-Howell test; *Pain-VAS on a scale from 0-100, 0 denotes no pain, 100 denotes worst imaginable pain; **EQ(5d): VAS on a scale from 0-100, 0 implicating the worst possible state of health, 100 implicating the best possible state of health;
+ HADS-D-Anxiety and -Depression-Score, both ranging from 0-21, the higher the score, the worse are anxiety or depression; # FACIT-Score ranging from 0-52, the higher the score, the better the quality of life; for multiple comparisons Bonferroni's correction was applied and significance threshold was set at 0.00625; significant differences are indicated in bold.
www.nature.com/scientificreports www.nature.com/scientificreports/ close to their workplace, i.e. with minimal waiting time both for the appointment as well as for the consultation itself. The consultation was offered to those out of more than 6000 employees of the participating companies, who described MSK-problems in the Nordic questionnaire. Employees were engaged in a variety of professions with a broad variety of physical demand on the individual, from very low (purely clerical work) to very high (cooks, cleaning personnel, welders, mechanics etc.). Therefore, we have captured a variety of physical symptoms in people with a broad range of physical workload with regard to location/body region as well as intensity of pain and quality of life.
The main outcomes of the study, in particular costs and types of treatment/therapy used by the participants appear to have been indeed, at least in part, been influenced by this comparatively simple and brief intervention. Out-of-pocket costs for therapeutic measures were significantly higher for the participants during the year following the consultation as compared to the year before the consultation. Furthermore, significantly more people engaged in active physiotherapy as well as in gymnastics/sports during the year following the consultation compared to the preceding year. Although the percentages still indicate that only a minority of the participants changed to a more active health behavior, the increases were remarkable: more than three times as many people took up physiotherapy, and more than nine times as many indicated to engage in sports/gymnastics. In contrast www.nature.com/scientificreports www.nature.com/scientificreports/ to this, a significantly lower percentage of the employees used NSAIDs (17.4%, a drop of almost 40% compared to baseline). Part of these individuals may have exchanged use of these side-effect-prone treatments for the mentioned "healthier" measures as well as for physical therapy (thermo-, electro-and mechanotherapy) which have significantly less systemic adverse effects. Use of analgesic medication with higher potency (WHO II and III opioids) was very low overall (approximately 1% at baseline), only one individual started tramadol during the year after the consultation.
We found significant differences related to gender in the distribution of painful regions: 50% more women than men indicated to suffer from pain in the cervical region and the upper limb. Cervical pain and upper limb pain generally was more frequent in women both working under high and low physical demand than in men. In contrast, low back pain affected all groups equally. To our knowledge, this difference is here reported for the first time and we believe this observation merits exploration in more detail, in particular from an occupational medical point of view. This could particularly inform preventive measures aimed at female employees.
Numerically, pain was more frequent in the HD working, especially in the limbs. This difference, however, was not significant after conservative correction for multiple observations [23] [24] [25] . Regarding the HADS-D depression score and the FACIT score we could also show worse scores in overall for HD working participants, which did not reach level of significance.
In line with published data, women indicated lower quality of life compared with men 26 , women with HD workload having the lowest, men with LD workload indicating the highest quality of life on the EQ-5d-scale. Likewise fatigue as measured by the FACIT fatigue scale was significantly higher in women than men, again with the highest fatigue (lowest score) in women under HD workload 27 . Because the study was aimed at individuals (of both sexes) who experienced MSK pain, 100% of the participants reported MSK pain. In accordance with data from the literature [28] [29] [30] [31] , the level of pain as evaluated by VAS was higher in women, whereas workload intensity appeared to have no significant influence on the level of pain experienced.
At baseline, a majority of the participants reported no previous diagnosis of MSD. After the specialists' assessment, approximately two thirds of the individuals were given a tentative diagnosis of MSDs by the specialist consultants. A further analysis of correctness of these "diagnoses" was impossible due to the patient-centered approach of this study. However, the number of individuals known to suffer from an inflammatory rheumatic disease increased from 6 before the baseline consultation to 28. Thus, 22 hitherto "healthy" individuals were suspected to be in need of further rheumatological workup/care.
The feasibility of offering an easy "low threshold" access to specialist health interventions was demonstrated by this initiative. Access thresholds to rheumatological care have been shown to severely delay early diagnosis (and treatment) of inflammatory rheumatic diseases, with possible negative influence on treatment outcomes 32 . Despite this very low threshold, most individuals had a duration of complaints of more than 2 years, with only a small minority (1.7%) knowingly having inflammatory MSDs. The percentage of individuals suspected to suffer from inflammatory MSDs increased to 8.1% after the consultation (although we were not able to confirm the suspected diagnoses after one year). This demonstrates that, especially in individuals who are actively employed, the tendency to ignore possibly dangerous symptoms is still substantial.
Of more than 6000 emplyees, approciamtely 6,7% took the opportunity to receive specialists' advice. This number may appear low, given the estimated prevalence of MSK symptoms. One explanation for the low turnout may lie in the obviously quite high "individual threshold(s)" to pay attention to symptoms: the median pain rating of the participants was 40 on a 100 mm VAS, a value regarded as qualifying for high intensity treatment, and only 25% of the participants had a VAS < 20. Therefore, the opportunity for a consultation appears to have been "by design" attractive only to individuals with at least moderate pain levels, generating some sort of "bias" towards people with higher degree of pain. Despite the readily available specialist counsel, a substantial number of individuals affected by "minor" symptoms seem to have let the offered opportunity pass. Furthermore, because such an analysis was outside the scope both of the "Stay active" project as well as of the follow-up study, we can only speculate on the overall prevalence of MSK symptoms of minor intensity.
Because it was not possible to include a comparison group (e.g. without intervention) in the study we cannot rule out "secular" effects, e.g. by only alerting employees to possible MSK problems by distributing the Nordic questionnaire (without the ensuing consultation). Another confounding factor for the interpretation of the Table 4 . Comparison of medical or non-medical treatments used by the participants between baseline and 12 months' follow-up. 235 participants with baseline and follow up data were included in the analysis. Data are numbers of participants (%); *McNemar-Test; **number of users (%); ***weak opioids such as tramadol; ****strong opioids such as morphine etc.
www.nature.com/scientificreports www.nature.com/scientificreports/ follow-up results is that it is impossible to distinguish effects of the intervention itself on pain and medication use from the effects whatever further health services (e.g. physician visits) were used in the 12 months following the consultation.
Taken together, the effects of the brief intervention offered to the participants appear to be substantial in terms of inducing beneficial health behavior such as increase of engagement in gymnastics/physiotherapy and improvement of overall well-being. These effects may be brief as we have not extended the study beyond one year. Still, the significant benefits seen may serve as an in incentive to establish and if possible, repeat such initiatives in the workplace setting on a broader scale.
